Igor Fisch is a co-founder of Selexis SA, a biotech company based in Switzerland. He grew the company from inception to profits in less than 5 years with up to > 5MCHF in revenues with a net margin > 20%. He has a proven track-record for achieving major licensing deals in the Biotech and Pharmaceutical industry in USA, Europe, Asia and Australia. Igor Fisch has a very strong network among decision makers and entrepreneurs worldwide in the Pharmceutical and Biotech industry.

Igor Fisch is also an Experienced Director, proactive manager and able, even in difficult environments, to set-up and motivate teams and to facilitate collaborations around ambitious objectives.

He is currently and since 2001 President of the Board of Directors and Chief Executive Officer of Selexis SA, where he was a Co-founder in charge of raising the capital to create a successful biotech company.

Igor Fisch is Member of the Board of Directors of Viroblock SA and a Member of the Strategy Council of the Venture Kick Initiative.